Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
The transaction consists of an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.
The transaction consists of an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.
Copyright 2025 | All Rights Reserved | Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.